TMS for nerve pain in cancer patients
Part of Brain & nervous system, Cancer, Pain clinical trials.
This trial tests if repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation, can reduce chronic nerve pain caused by cancer or its treatment. It may help patients who have not found relief from standard pain medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 85 years old
- You have nerve pain related to cancer or its treatment that has lasted more than 4 months
- Your pain is at least 4 out of 10 on a standard pain scale and occurs almost daily
- Standard pain medications have not fully relieved your pain
- Your pain medications have been stable for at least 1 month
- You are willing to undergo rTMS and MRI scans, and have no metal implants or other contraindications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a form of brain stimulation (rTMS) can reduce chronic nerve pain that has lasted more than a year and hasn’t improved with standard treatments. It may help people whose usual pain medicines are stable but still not working well.
This trial tests whether a non-invasive magnetic brain stimulation treatment can help manage cancer-related pain. It may be an option for people with cancer pain who are not helped enough by current treatments.
This study tests two types of magnetic brain stimulation (aiTBS and rTMS) to treat long-lasting nerve pain. Researchers want to see which approach works better and develop a way to predict who will benefit most.
This trial tests whether a noninvasive brain stimulation technique (rTMS) can help people with long-term nerve pain who also have depression. It aims to see if this treatment can reduce pain and improve mood.
This study tests a non-invasive type of brain stimulation called rTMS for people with frequent or chronic migraine who have not found relief from at least 3 prevention medications. The goal is to see if this treatment can safely reduce pain.
This trial tests if transcranial magnetic stimulation (TMS), a noninvasive brain treatment, can reduce nerve pain caused by chemotherapy in women who have had breast or gynecologic cancer. You may be eligible if you have ongoing nerve pain that hasn't been helped by standard pain medications.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.